INTERNATIONAL PATENT: ADCENTRX THERAPEUTICS INC., ADCENTRX THERAPEUTICS SHANGHAI CO., LTD. FILES APPLICATION FOR "METHODS AND COMPOSITIONS RELATED TO ANTIBODY DRUG CONJUGATES (ADCS) THAT BIND STEAP-1 PROTEINS"

GENEVA, Dec. 31 -- ADCENTRX THERAPEUTICS INC. (5580 Morehouse Drive, Suite 210San Diego, CA 92121), ADCENTRX THERAPEUTICS SHANGHAI CO., LTD. (No. 865 Zuchongzhi RoadNexxus Life Science Park, 1st Floor, Bldg. 2Pudong New Area, Shanghai) filed a patent application (PCT/US2025/033735) for "METHODS AND COMPOSITIONS RELATED TO ANTIBODY DRUG CONJUGATES (ADCS) THAT BIND STEAP-1 PROTEINS" on Jun 16, 2025. With publication no. WO/2025/264533, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHALLITA-EID, Pia (5580 Morehouse Drive, ...